Prestige Wealth Management Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.14M | Buy |
3,138
+16
| +0.5% | +$5.48K | 0.21% | 70 |
|
|
2026
Q1 | $1.1M | Sell |
3,122
-91
| -3% | -$32.4K | 0.22% | 60 |
|
|
2025
Q4 | $1.05M | Buy |
3,213
+1,758
| +121% | +$558K | 0.2% | 65 |
|
|
2025
Q3 | $411K | Buy |
1,455
+88
| +6% | +$25.5K | 0.08% | 124 |
|
|
2025
Q2 | $382K | Buy |
1,367
+350
| +34% | +$99.2K | 0.08% | 123 |
|
|
2025
Q1 | $317K | Buy |
1,017
+27
| +3% | +$7.97K | 0.07% | 130 |
|
|
2024
Q4 | $258K | Sell |
990
-397
| -29% | -$118K | 0.05% | 145 |
|
|
2024
Q3 | $447K | Buy |
1,387
+38
| +3% | +$12.4K | 0.09% | 108 |
|
|
2024
Q2 | $422K | Buy |
1,349
+966
| +252% | +$284K | 0.09% | 97 |
|
|
2024
Q1 | $109K | Sell |
383
-25
| -6% | -$7.32K | 0.02% | 193 |
|
|
2023
Q4 | $117K | Sell |
408
-6
| -1% | -$1.64K | 0.03% | 174 |
|
|
2023
Q3 | $111K | Sell |
414
-111
| -21% | -$27.7K | 0.03% | 178 |
|
|
2023
Q2 | $117K | Sell |
525
-1,560
| -75% | -$362K | 0.03% | 194 |
|
|
2023
Q1 | $504K | Buy |
2,085
+1,507
| +261% | +$370K | 0.13% | 86 |
|
|
2022
Q4 | $152K | Sell |
578
-1,324
| -70% | -$355K | 0.04% | 155 |
|
|
2022
Q3 | $428K | Buy |
1,902
+101
| +6% | +$24.5K | 0.12% | 80 |
|
|
2022
Q2 | $438K | Buy |
1,801
+173
| +11% | +$42.4K | 0.12% | 82 |
|
|
2022
Q1 | $393K | Buy |
1,628
+1,274
| +360% | +$293K | 0.1% | 96 |
|
|
2021
Q4 | $79K | Sell |
354
-10
| -3% | -$2.11K | 0.02% | 223 |
|
|
2021
Q3 | $77K | Buy |
364
+158
| +77% | +$36.4K | 0.02% | 212 |
|
|
2021
Q2 | $50K | Sell |
206
-152
| -42% | -$37.4K | 0.01% | 246 |
|
|
2021
Q1 | $89K | Buy |
358
+17
| +5% | +$4.06K | 0.02% | 192 |
|
|
2020
Q4 | $78K | Sell |
341
-662
| -66% | -$153K | 0.02% | 200 |
|
|
2020
Q3 | $255K | Buy |
1,003
+115
| +13% | +$28.5K | 0.08% | 98 |
|
|
2020
Q2 | $210K | Buy |
888
+110
| +14% | +$25.1K | 0.07% | 94 |
|
|
2020
Q1 | $158K | Buy |
778
+149
| +24% | +$32.5K | 0.07% | 90 |
|
|
2019
Q4 | $152K | Sell |
629
-6
| -0.9% | -$1.32K | 0.08% | 134 |
|
|
2019
Q3 | $123K | Buy |
635
+21
| +3% | +$4.03K | 0.07% | 138 |
|
|
2019
Q2 | $113K | Buy |
614
+399
| +186% | +$71.4K | 0.07% | 143 |
|
|
2019
Q1 | $41K | Sell |
215
-142
| -40% | -$27.1K | 0.03% | 199 |
|
|
2018
Q4 | $69K | Buy |
+357
| New | +$69.6K | 0.05% | 166 |
|
Other funds holding AMGN
Prestige Wealth Management Group's AMGN Position: Q2 2026 in Review
Prestige Wealth Management Group increased its Amgen (AMGN) stake by 0.51% in Q2 2026, buying an estimated $5.48K and bringing the position to 3,138 shares worth $1.14M. The position accounts for 0.21% of the portfolio, ranked #70.
Prestige Wealth Management Group first reported a position in AMGN in Q4 2018 and has held it in 31 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Prestige Wealth Management Group held 3,138 shares of Amgen worth $1.14M as of Q2 2026.
- Prestige Wealth Management Group bought 16 Amgen shares in Q2 2026, an estimated $5.48K.
- Amgen made up 0.21% of Prestige Wealth Management Group's portfolio in Q2 2026, its #70 holding.
- Prestige Wealth Management Group first reported a position in Amgen in Q4 2018 and has held it in 31 quarters since.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Prestige Wealth Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.